Quantbot Technologies LP Alaunos Therapeutics, Inc. Transaction History

Quantbot Technologies LP

  • $2.36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$2.63 - $3.67 $129,659 - $180,931
-49,300 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$2.82 - $5.6 $139,026 - $276,080
49,300 New
49,300 $177,000
Q3 2020

Nov 16, 2020
SELL
$2.39 - $3.43 $5,258 - $7,546
-2,200 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$2.2 - $3.71 $4,840 - $8,162
2,200 New
2,200 $7,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email